Texas CDMO is cutting 60% of staff as focus shifts to drug discovery
03 Nov 2022 //
ENDPTS
CDMO makes an AI and drug discovery play in latest, small-time acquisition
22 Sep 2022 //
ENDPTS
iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline
21 Sep 2022 //
GLOBENEWSWIRE
RubrYc Therapeutics Announces Series A2 Preferred Share Funding
25 Aug 2021 //
BUSINESSWIRE
RubrYc Announces a Research Collaboration and License Option Agreement
14 Apr 2021 //
BUSINESSWIRE